Episoder
-
In this week’s special bonus episode, we had the honor of speaking with Professor Craig Garthwaite, Associate Professor of Strategy and the Director of Healthcare at Kellogg. Professor Garthwaite is an applied microeconomist whose research examines the effects of government policies and social phenomena with a focus on the health and biopharmaceutical sectors. His recent work has focused on the private sector effects of the Affordable Care Act, including the labor supply effects of large insurance expansions, the changes in uncompensated hospital care resulting from public insurance expansions, and the responses of non-profit hospitals to financial shocks. In prior work, he has examined the impact of government cash assistance programs on health and the effect of changes in expected mortality from the emergence of crack-cocaine markets on educational attainment. Professor Garthwaite has testified before the United States House of Representatives and several state legislatures on matters related to the minimum wage and health care reforms.
Professor Garthwaite also studies questions of pricing and innovation in the biopharmaceutical sector. In this area, he has examined the effect of expanded patent protection on pricing in the Indian pharmaceutical market, the innovation response of United States pharmaceutical firms to increases in demand, and the relationship between health insurance expansions and high drug prices.
His research has appeared in journals such as the Quarterly Journal of Economics, the American Economic Review, the Review of Economics and Statistics and Health Affairs, and you have likely seen his work and interviews in the Wall Street Journal, the Washington Post, and Vox. He has also appeared as a guest on various television and radio shows such as Nightly Business Report and NPR Marketplace. In 2015, Professor Garthwaite was named one of Poet and Quants 40 Best under 40 Business School Professors.
A few of the topics that Chuck and Professor Garthwaite cover in the episode include:
Professor Garthwaite’s background and how he arrived at his position at Kellogg The causes behind why we are seeing a recent trend in vertical integration among players in the healthcare space The incentive alignments between mergers such as CVS and Aetna and what the lay consumer might not understand about the benefits of such a merger Professor Garthwaite’s thoughts around what can be done about the high drug prices in the US Professor Garthwaite’s perspective on the Amazon- Berkshire-JPMorgan health venture and ideas around what these 3 companies aiming to achieve together Many point to misaligned physician incentives or the increase in diabetes or people not leading healthy lifestyles, that lead to the high healthcare costs in the US but Professor Garthwaite shares other factors to consider in this debate as well The tradeoff between innovation and access to care and how Professor Garthwaite defines innovation The type of “disruption in healthcare” Professor Garthwaite thinks truly has merit and will have impact Professor Garthwaite’s current research on Hospitals as Insurers of Last Resort and how hospitals may not be passing along all uncompensated-care costs to other parties such as hospital employees or privately insured patientsConnect with Professor Garthwaite:
Kellogg Profile Professor Garthwaite on Twitter LinkedIn Healthcare at KelloggConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn -
This week’s bonus interview welcomes Lee Shapiro of 7Wire Ventures to the podcast. Lee is Managing Partner at 7wire Ventures, an investment firm he co-founded over a decade ago. The fund’s focus is on building companies that empower connected informed health consumers to improved outcomes, facilitating the change from sick-care to wellcare. He is active with the 7wire portfolio and the boards of Livongo Health, Ayogo Health, Carebox, Zest Health, ConsejoSano, Modern Teacher and Education Funding Partners. He also serves on the boards of Medidata Solutions [NASDAQ:MDSO], Tivity Health [NASDAQ:TVTY], and Aptus Health (a Merck subsidiary [NYSE:MRK]).
As President of Allscripts [NASDAQ:MDRX] from 2001 through 2012, his leadership was central to over $4B in mergers, acquisitions and financings. He oversaw the company's strategy, international operations, business development and partnerships, health plan initiatives and entrepreneurial business investments.
He is a member of The World Innovation Network Board (TWIN, formerly known as Northwestern Kellogg KIN), the University of Chicago Innovation Fund Advisory Committee, The Samsung Strategic Advisory Board, The Qualcomm Life Advisory Council and the advisory board for the Center of Digital Innovation in Digital Health in Beer-Sheva, Israel.
Lee is a member of the National Board of Directors of The American Heart Association and has served as an officer and director of the Gastro-Intestinal Research.
Also joining this episode was special guest, and Healthbox President, Neil Patel.
In this Episode, Chuck, Neil, and Lee discuss:
Lee’s early career, how he became President of AllScripts and some of the biggest lessons he learned at Allscripts How Lee realized and arrived at the investment thesis for 7Wire Ventures? Lee’s vision in creating, essentially, a 2-sided market, with startups on one side and 7wire’s strategic LPs on the other, which includes such names as Horizon Blue Cross Blue Shield, Memorial Hermann, and Rush University Medical Center, to name a few. With such a diverse set of strategic LPs, Lee’s philosophy on how to engage them in the investment process and in portfolio support Lee’s thoughts around innovation in Chronic care management and if, due to the recent emergence of advanced IOT and AI, we are on the cusp of seeing some major changes in this area What gave Lee the conviction early on to invest in a crowded disease management space, having participated in many of Livongo’s early funding rounds Lee’s approach to looking for and identifying new innovative healthcare business models and how the firm proactively looks to foster these types of models What Lee thinks is special about having his firm based here in the MidwestConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or LibsynConnect with Lee:
7Wire Ventures 7Wire Twitter LinkedIn -
Manglende episoder?
-
This week’s episode welcomes Erik Pupo, managing director in the Accenture Health Client Service Group, for the final part in our series around Blockchain Innovation in Healthcare. Erik is Accenture’s Healthcare Blockchain lead for North America, where he leads sales and implementation efforts with Accenture’s payer, provider, and life science customers on how to use blockchain technology to improve efficiencies within their businesses.
Erik has worked for over 20 years in healthcare, including senior positions in federal, state, and commercial healthcare programs and initiatives, and served in key leadership roles within the healthcare community. A speaker and thought-leader on trends influencing the healthcare industry, Eric holds leadership advisory positions within the American Health Information Management Association, the Healthcare Information and Management Systems Society, where he also became a fellow in 2012, and the Healthcare Financial Management Association. Previously, he worked at Deloitte where he led several health IT initiatives for the Office of the National Coordinator for Health IT, the Department of Defense, and the Department of Veteran Affairs (VA).
In this Episode, Chuck and Erik cover:
Erik’s background and how he became interested in the blockchain Erik’s team and his role inside Accenture and the types of projects and thought leadership they produce How one “builds a blockchain” Who can actually touch or use the blockchain in a practical sense If different blockchains are interoperable with one another or can they be adjusted to be Blockchain innovation in the pharmaceutical industry How the blockchain can be used to help underserved populations and rural communities Erik’s advice to entrepreneurs building technology in the Blockchain space and to healthcare organizations who want to implement Blockchain technologyConnect with Erik:
Accenture Twitter LinkedInConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected]Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
-
Our guest today, John Bass, joins the podcast to talk about the use of the blockchain in healthcare and how it will drive innovation, now, and in the future. John is CEO of Hashed Health, a healthcare blockchain innovation firm focused on building the new digital infrastructure for healthcare. John has over 20 years of experience in healthcare technology with expertise in shared operating systems that build trust, transparency, and incentives across health networks.
Prior to Hashed Health, John was CEO at InVivoLink, a care management start-up which sold to HCA in 2015. Since then, John has been a leading voice in the development of the global healthcare blockchain market and is focused on community development, enterprise services, and blockchain solutions development.
Topics we cover in this episode:
John’s background and focus on improving patient outcomes When the blockchain actually came to be and when and why it piqued John’s interest What the blockchain is The types of problems using the blockchain in healthcare aims to solve and how Hashed Health aims to accelerate this process How the blockchain will truly be disruptive in healthcareConnect with John:
LinkedIn TwitterConnect with Hashed Health:
Website Twitter Resources https://chat.hashedhealth.com https://hashedhealth.com/blockchain-healthcare-resources/Connect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected]Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
-
Our guest today, Adrian James, joins the podcast to talk about innovation in the chronic care management space for the second episode in our series on this topic. Adrian is Co-Founder and President of Omada Health, a digital behavioral medicine company using behavior science to help people change their habits, improve their health, and reduce their risk of chronic disease.
Prior to co-founding Omada Health, Adrian led the medical products division of IDEO’s health practice where he focused on business development and client relationships, ranging from industry startups to Fortune 500 healthcare companies. Adrian also holds a BS and MS in Mechanical Engineering from Stanford University.
In this episode, Chuck and Adrian discuss:
Adrian’s background, career at IDEO, and what led him to start Omada Health How the Omada Health platform works and how the company approaches taking a process that was typically done in person and delivering it digitally, while ensuring compliance and success The types of outcomes Omada has been able to achieve to date The importance of users on the Omada platform to be part of the communities within the platform and the importance of interpersonal touchpoints How Omada takes a user-centered design approach to make the product “sticky” and to keep people coming back to it What it was like raising the first money for the company and what was going on in the early stages of development How Omada plans to deploy the $50M recently raised in the company’s Series C round Adrian talks about Omada’s recently launched randomized trial of digital diabetes care in partnership with the University of Nebraska Medical Center to further gauge the efficacy of its program, which aims to keep those at risk for diabetes from developing the disease "The PREDICTS trial is the next step in that evolution—it will track a range of healthcare and other outcomes, while establishing the highest level of clinical evidence for the effectiveness of a digitally-delivered intensive behavioral counseling program." Adrian’s advice to early entrepreneurs trying to innovate in the digital health space and what he thinks are key things to strive for or be on the lookout forConnect with Adrian:
LinkedIn TwitterConnect with Omada Health:
Website TwitterConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn -
Our guest today, Anand Parikh, General Counsel and Head of Business Development at Virta Health, joins the podcast for the first part in our series on Innovation in Chronic Disease Management. Anand began his career as Senate Fellow for the California State Senate and a clerk for the United States District Court. He then practiced at Morrison & Foerster LLP before joining Virta in 2015 as the company’s Chief of Staff, and 5th employee, and moving into his current role in 2016.
Virta is a treatment that safely and sustainably reverses type 2 diabetes without medications or surgery. Virta achieves this through innovations in nutritional biochemistry, data science, and digital tools combined with clinical expertise to shift the diabetes treatment paradigm from management to reversal. The company’s mission is to reverse type 2 diabetes in 100 million people by 2025 and they have some exciting clinical evidence and proven patient results to support that goal.
In this episode, we cover:
Anand's background and his career and what led him to Virta The evidence that existed behind what Virta was trying to achieve when he joined the company The story of how the company came to be, how it was founded, and where the original business model came from Anand’s main responsibilities as General Counsel and Head of Business Development How the Virta Health model works from a diet and coaching perspective How Virta's technology platform has evolved over time How Virta leverages the data collected to iterate on the platform How Virta has taken something like diabetes treatment, which is inherently a high-touch and personal, and added a technology layer while ensuring not only patient buy-in but compliance The uses of behavioral economics Virta Health employs to drive patient change Anand tells us about the exciting results of Virta Health’s recent 1 Year Clinical trial The main goals of Virta’s recent fundraiseConnect with Anand:
Virta Health Twitter LinkedInConnect with Virta
Website Twitter Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 YearConnect with Healthbox
Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on iTunes, SoundCloud, or Libsyn -
Happy new year from the Healthbox and the Podcast team! We are working hard on some great new series coming up in 2018 but before releasing those, we sat down with Healthbox President Neil Patel to hear about what he’s seeing in the healthcare innovation space and what he is predicting for 2018.
In this episode, Chuck and Neil cover:
New podcasts series that will be coming early this year, including Non-emergent medical transportation The use of the Blockchain in healthcare Innovation in Chronic care disease management A discussion around innovation and regulation from a government standpoint, including the FDA’s 2018 roadmap, which includes: Four strategic policy areas: addiction crises, innovation, consumer empowerment and the FDA workforce Reduce the burden of addiction crises that are threatening American families Leverage innovation and competition to improve healthcare, broaden access, and advance public health goals Empower consumers to make better and more informed decisions about their diets and health; and expand the opportunities to use nutrition to reduce morbidity and mortality from disease Strengthen FDA’s scientific workforce and its tools for efficient risk management What Neil is most excited about for healthcare innovation in 2018Connect with Healthbox:
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected]Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
-
Today’s guest, Jason Calacanis, joins host Chuck Feerick to talk about his new book “Angel”, what it takes to be a successful angel investor, and a variety of other topics.
Jason is a technology entrepreneur, angel investor, and the host of two very popular podcasts, This Week in Startups and Angel. He got his start in the world of startups in New York and his second company, Weblogs inc., was sold to AOL in 2005, after which Jason became a “scout” for top-tier Silicon Valley venture capital firm Sequoia Capital. Since then, Jason has gone on to launch numerous ventures and is currently the founder of a series of conferences that bring entrepreneurs together with potential investors, frequently appears in the media, and most notably is a successful angel investor in over 100 companies, including both Thumbtack and Uber.
In this episode, Chuck and Jason discuss:
Jason’s earliest role in New York with Silicon Alley reporter and what he learned about entrepreneurship in that process Jason’s first angel investment Why Jason decided to write a book, why now, and why he wants to give away all his best practices and secrets Where Jason says it is most important to be located geographically to be a great angel investor When meeting with a founder, what Jason believes are the most important things an aspiring angel should ask What Jason feels is the best way that angel investors can be helpful to their portfolio companies If Jason thinks that angel investors should stick to investing in the industries they know (e.g. should a doctor only invest in healthcare)? Regarding startup crowdfunding platforms, whether or not Jason feels these platforms are the best place for an angel investor to start and if some are better or safer than others What Jason thinks about ICOs What book, besides Angel, Jason thinks everyone should read Which of Jason’s investments he is most excited about right nowConnect with Jason:
Twitter This Week in Startups Angel Podcast LAUNCH Festival LAUNCH Incubator Buy Jason’s book, Angel or on Amazon Jason's Private SyndicateConnect with Healthbox:
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn -
This week’s episode is a special bonus episode recorded live at the 2017 Healthbox Fall Forum with three fantastic guests. The theme of the Fall Forum was Innovating Behavioral Change in Healthcare and each of our guests reflected on their biggest takeaways of the Forum and what they can do at their organizations with the knowledge they gained.
Featured in this episode are:
Desert Horse-Grant, Senior Director, Research and Innovation at UCLA Health LinkedIn UCLA Health Alec Zopf, CTO of Wellth LinkedIn Twitter Wellth David Hochheiser, SVP Provider Networks & Healthcare Value at BCBS Louisiana LinkedIn BCBS Louisiana -
Our guest today, Dr. Sam Volchenboum, is the Associate Professor of Pediatrics, Associate Chief Research Informatics Officer, and Director, Center for Research Informatics at University of Chicago Medicine. Dr. Volchenboum is an expert in pediatric cancers and blood disorders. He has a special interest in treating children with neuroblastoma, a tumor of the sympathetic nervous system.
In addition to caring for patients, Dr. Volchenboum studies ways to harness computers to enable research and foster innovation using large data sets. He directs the development of the International Neuroblastoma Risk Group Database project, which connects international patient data with external information such as genomic data and tissue availability. The Center he runs provides computational support for the Biological Sciences Division at the University of Chicago, including high-performance computing, applications development, bioinformatics, and access to the clinical research data warehouse. He is also currently collaborating with Google to use machine learning for better health care and has been written about in both Wired.com and the Washington Post. If all that wasn’t enough, Dr. Volchenboum is also co-founder of Litmus Health, a data science platform for early-stage clinical trials.
In this Episode, Chuck, new Healthbox team member and guest host Jessica, and Dr. Volchenboum discuss:
Why Dr. Volchenboum chose to earn a Master’s in Biomedical Informatics from MIT and Harvard Medical School and how he merged that with his passion for computer science What the old way predictive modeling looked like and how data was made actionable, before the use of current applications of artificial intelligence What the U Chicago Medicine’s Center for Healthcare Delivery Science and Innovation is focused on and some of the biggest problems Dr. Volchenboum and his team are working to solve How Dr. Volchenboum’s collaboration with Google came to be, the big problems being tackled, and which of Google’s tools are being used As co-founder of Litmus Health, Dr. Volchenboum talks about the company and what spurred him to make the entrepreneurship leap What’s next for both Dr. Volchenboum’s Google collaboration and at Litmus HealthConnect with Dr. Volchenboum and his work:
LinkedIn U Chicago Profile UChicago Medicine collaborates with Google to use machine learning for better health care UChicago Medicine and Google — a data-driven duo to watch Data Commons to Support Pediatric Cancer Research Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs Blog post Litmus HealthConnect with Healthbox:
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected]Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
-
Our guest today, Elad Benjamin, joins the podcast from Israel for the second episode in our series on innovation and the use of AI in healthcare. Elad is CEO and Co-Founder of Zebra Medical Vision and is a veteran Healthcare IT executive with over 20 years of experience in software and medical devices, in both startups and Fortune 500 companies. He has held senior roles in Healthcare IT companies, including playing key roles in taking companies public on the NASDAQ as well as managing complex global businesses implementing solutions in medical providers worldwide. Elad holds a BsC from Tel Aviv University and earned his MBA from the Stanford Graduate School of Business.
In 2014, Elad co-founded Zebra Medical Vision, an automated medical imaging diagnostic engine featuring a vast database and using machine learning to create diagnostic insights that will help physicians be more effective in treating their patients. To date, Zebra Medical Vision has raised over $20 million in venture funding from top tier firms including Khosla ventures, SalesForce co-founder Marc Benihoff, and Intermountain Healthcare.
In this episode, Chuck and Elad discuss:
Elad’s background and how he initially got into healthcare and healthcare technology Where the idea for Zebra Medical Vision came from The biggest lessons Elad has learned from running his first company to now being at the helm of Zebra Medical How Zebra Medical ensures the AI within the platform only learns from the best data and gets smarter over time while staying uncorrupted How fast Elad believes the use of AI is moving in healthcare and how far he thinks we are from something truly industry/world changing How Elad earned investments from some of the world’s most well known venture capital firms The importance of the makeup of the Zebra Medical Board and what Elad looks for from a board member with such a technical businessConnect with Elad:
LinkedIn TwitterConnect with Zebra Medical Vision:
Website TwitterConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn -
Our guest today, Kevin Freedman, joins me to talk about innovation and the use of AI in healthcare. Kevin is founder of NextPhase Partners, a firm providing independent support and guidance to entrepreneurs as they guide their companies through their next phases of growth. Prior to NextPhase, Kevin was an operating partner at Khosla Ventures and has more than 15 years of operating experience with leadership roles in both consumer and enterprise technology companies.
Before joining Khosla Ventures, Kevin was the CEO of Quid, a leading SaaS business intelligence platform, which Fortune 500 companies from Intel and McKinsey to Samsung and Barclays, among others, utilize to better understand the web’s unstructured data. Prior to Quid, he was an early executive at Slide, and took on the role of CFO where he built out the company’s business functions as they scaled to 150 million monthly users and ultimately drove the acquisition by Google.
Earlier in his career, Kevin held a variety of senior operating roles at eBay and PayPal, with his initial success in Silicon Valley beginning with Half.com, which was acquired by eBay in 2000.
In this episode, Chuck and Kevin discuss:
Kevin’s background, and the path that led him into the world of startups and venture capital What are the roles and responsibilities of an “operating partner” How the investment in Zebra Medical Vision came to be and what got Kevin interested in taking a board seat The impact that Kevin thinks AI will play in Healthcare moving forwardConnect with Kevin
LinkedIn TwitterConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected]Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
-
This week’s bonus episode was recorded live at the 2017 Healthbox Studio Showcase! Healthbox hosts the program to support and advance entrepreneurial innovation, which aligns with our overall mission to empower the reinvention of healthcare. The program helps accelerate emerging digital health companies and fosters relationships between startup founders and industry leaders. Healthbox hosts the program free of charge to selected companies with no required equity exchange. The Studio ran from October 9-13 at the Healthbox office in Chicago, IL and featured presentations, workshops, and mentor sessions from the Healthbox team and other industry leaders.
In this episode, host Chuck Feerick sat down with four participants from the Studio to explore what their companies do and the problems they solve, what some of their biggest takeaways from the week were, a favorite session or two from the week, and what is the first thing they’ll do once they get back to their teams
Our guests included:
Chris Wyatt, VP of Strategy and Sales at Parasail Health
Parasail Health helps providers and patients focus on treatment instead of payment by offering a suite of products that make medical bills affordable for patients and get providers paid right away.
Follow Parasail Health on Twitter @ParasailHealth
Matt Pierce, Co-Founder and CEO at TrustedHealth
Trusted Health is on a mission to improve access to care by optimizing the healthcare workforce. Their automated matching platform connects the right candidates with the right opportunities better and faster than ever before, starting with America's most trusted profession, nurses.
Follow TrustedHealth on Twitter @Trustednurses
Andrew Trees, Co-Founder and CEO at Agathos:
Agathos is a mobile analytics platform that empowers physicians to optimize their practice patterns and demonstrate the value of the care they provide.
Follow Agathos on Twitter @AgathosHealth
Bora Chang, Co-Founder & CEO at Kela Health
KelaHealth predicts risk for surgical complications using machine learning & proactively intervenes by guiding surgeons on best-practices at the point-of-care to decrease complications and improve quality of care.
Follow Kela Health on Twitter @KelaHealth
Connect with Healthbox
Follow us on Twitter and @Chuckfeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn -
Our guest today, Drew Schiller, Co-Founder & CEO at Validic, joins Chuck on the Podcast for the final episode in our series around interoperability in Healthcare. Validic is a technology platform for convenient, easy access to digital health data from best-in-class clinical and remote-monitoring devices, sensors, fitness equipment, wearables and patient wellness applications.
Prior to co-founding Validic, Drew founded and ran a web development firm, founded and exited a niche dietary nutrition website for patients with celiac disease, and served as an Adjunct Instructor at the University of Iowa teaching graduate courses in web development and usability. Drew is currently a Board Member of the Consumer Technology Association (CTA) Health & Fitness Technology Division and serves on the Leadership Council for the eHealth Initiative (eHI) and participate in the eHI Interoperability Workgroup. On top of that, he is also an advisor for the Clinical Trials Transformation Institute Mobile Devices Project to advance the use of mobile devices in clinical trials.
In this episode, Chuck and Drew discuss:
Drew’s background, and the path that led him to start Validic How the Validic platform works and helps solves interoperability issues in healthcare How Validic works with partner companies to ensure the data is secure and HIPAA compliant Validic’s recent developments with Microsoft and how Microsoft HealthVault Insights is integrating Validic into its platformConnect with Drew
LinkedIn TwitterConnect with Validic:
Website TwitterConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn -
On this week’s episode, we welcome Leland Brewster back on the program for the second part of our series around interoperability in healthcare! Leland is the Director of Fund Management for Healthbox and supports Intermountain Innovation Fund-related activities and heads Healthbox's seed investments in addition to supporting portfolio management efforts across all of its investment vehicles. Prior to joining Healthbox, Leland worked for Clarion Healthcare, a boutique life sciences consultancy in Boston. At Clarion, he was involved in multiple product commercialization and launch readiness projects, as well as the design and launch of a one-of-a-kind patient and physician support program. Leland received his BA in Economics and Chemistry from Williams College and received his MBA from Chicago Booth.
In this episode, Chuck and Leland discuss:
The Intermountain Innovation Fund and the areas the fund is interested in investing What the evolution of the thesis of the fund has looked like and what led to that progression How the Intermountain fund differentiates from other strategic hospital funds and how they work with other strategic hospital funds How the relationship between Redox and Healthbox came to be and how that evolved into an investment How Leland looks at the current state of interoperability How Intermountain became interested in making an investment in Redox What about Redox and the team made Leland say “yes”Connect with Leland
LinkedIn TwitterConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn -
This week’s episode is the first part of our new podcast series around Interoperability. Joining host Chuck Feerick on the program is Niko Skievaski, the Co-founder and President of Redox. Based in Madison Wisconsin, Niko started Redox in 2014 to reduce barriers to entry in healthcare technology and has thus created a Modern API for EHR integration. Niko is a board member and co-founder of 100State, Wisconsin’s largest co-working space as well as co-founding BreadcrumbsQA, a searchable Q&A knowledge management platform originally deployed at Epic.
In this episode, Chuck and Niko cover:
Niko’s background and the path that led him to start Redox The problem Redox solves, how Redox works, and why a solution like Redox is so important Redox’s partnership with CloudMine and what the partnership looks like, as well as other partnerships What the current state of the interoperability market looks like today and what sets Redox apart The interplay between FHIR and the APIs the government promised in the 21st Century Cures Act, as well as the new marketplaces from companies such as Athena, Cerner, and Epic What Niko says has been the hardest part about building the company What the fundraising process was like for Redox and how Niko helped investors understand the magnitude and ROI on this problem Why Niko and team decided to found the company in Madison, Wisconsin and how Madison is in terms of its startup community and resourcesConnect with Niko
LinkedIn TwitterConnect with Redox
Website TwitterConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected]Listen to this episode on iTunes, SoundCloud, or Libsyn
-
This week we have a bonus episode of the podcast with Jeff Hyman, Founder and Chief Talent Officer of Strong Suit, a firm that helps build Rockstar top-teams for VC & PE portfolio companies. In addition to founding Strong Suit, Jeff is an Adjunct Professor at the Kellogg School of Management, is the Author of The Ultimate Guide to Hiring Growth Rockstars and the Host of the iTunes rated 5-star Strong Suit Podcast, and is CEO-in-Residence at Sterling Partners, a $6B Chicago PE firm. Along the way to founding Strong Suit, Jeff has raised $55M in venture capital, and has been CEO and Founder of 4 different companies, including Chicago-based Retrofit, where he is now Chairman.
Jeff joins us on the program today to talk about Finding and Hiring Rockstars at your Startup and how to avoid costly mistakes in this crucial process.
Topics we discuss in this episode include:
Jeff’s background and what led him to building a company in the healthcare space The astonishing number of times Jeff got rejected before one the world's most prominent investors said “yes” to him How Jeff defines a “rockstar”? How a busy founder can build in more time to focus on recruiting How to balance hiring for talent vs. culture and, How Jeff ensures he hires for diversity among teams The best questions to ask during the actual interviewLinks and Resources:
The Strong Suit 8 Immutable Truths of Talent for VC & PE Companies. 1. People are the ultimate competitive differentiation Creating a culture that draws in talent is the only way to stay ahead for the long term. 2. There is no such thing as a perfect candidate You’ll be waiting forever. Instead, identify the must-have competencies & never settle. 3. Recruiting is sales & marketing, not human resources It’s all about the funnel. First, plug the leaks. Then, fill the funnel. 4.You must give top-performers a reason to listen Rockstars have never had more options. You need to create a compelling employer value proposition. 5. Recruiting must be based on things that are predictive of success DNA is far more predictive than experience, education, or personality. 6. A top-performer at one company is not always a top-performer at another There are no shortcuts, even if they worked at your competitor. 7. Using your “gut” in recruiting is right 50% of the time But which 50%? Trust the process, and increase your accuracy to 90% or more. 8. To build a successful business, winning the war for talent must be your #1 priority You must invest at least 30% of your time on recruiting & retention.Connect with Jeff
LinkedIn Twitter Strong Suit Strong Suit Podcast (iTunes)Connect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on iTunes, SoundCloud, or Libsyn -
This week’s episode is the third and final installment of our series in On-Demand Healthcare. Our guest today is Kelly Perdew, Managing General Partner of Moonshots Capital – an early stage angel syndicate that invests in early stage technology companies and leans in heavily on veteran founded companies. He is co-founder & Managing Partner at The DuMont Project – a consultative agency that helps accelerate the growth of direct to consumer brands. Prior to DuMont Project he was the CEO of Fastpoint Games, a venture-backed leading developer of live data-driven games for the fortune 500 brand set.
Kelly earned a BS from the US Military Academy, West Point, a JD from the UCLA School of Law, and an MBA from the Anderson School at UCLA. Kelly served in the US Army as a Military Intelligence Officer and completed Airborne and Ranger training and is also an accomplished author and speaker on leadership.
At Moonshot Capital Kelly and his cofounder Craig Cummings bring a disciplined approach to the investment process to identify companies with exceptional growth potential. They form close working relationships with the companies they back to help them achieve their critical milestones and frequently take on Board seats or formal advisory roles. As West Point graduates and veterans, they look to invest 50% of all deals in companies that are military veteran founded or run.
In addition to all of this, Kelly was the winner of the 2nd season of NBC’s “The Apprentice”!
In this Episode, Kelly speaks with Chuck and Healthbox Fund Associate Caroline Arenz about:
Kelly’s fascinating background and experience After his experience as a company founder and CEO, how Kelly got into Angel and venture investing How Kelly defines a “moonshot” and his clear set of determining factors that allows him to make quick “no” decisions How Kelly got interested in On-Demand Healthcare and what led to his investment in PlushCare and why he considers PlushCare a “moonshot” What Kelly thinks thats healthcare companies could learn from taking ideas from other industries Of the 10 point checklist of selection criteria for companies Kelly invests in, which are the most important things he is looking for in the company founders he looks to invest inLinks
Connect with Kelly
LinkedIn Twitter WebsiteConnect with Moonshots Capital
Twitter WebsiteConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on iTunes, SoundCloud, or Libsyn -
This week we have Sameer Khanna, VP of Engineering at Pager on the program in the second part in our series around on-demand healthcare, specifically the use of AI in on-demand healthcare!
Sameer holds a bachelors in Information Technology from Rochester Institute of Technology and a Masters of Computer Science from NYU. Prior to joining Pager, Sameer served as a key contributor at Lot18, successfully positioning the company as one of the largest wine e-commerce businesses. He then joined Viyet as CTO, and drove company revenue to 15x within 12 months with the construction of an e-commerce storefront, seller portal, and redesign of the marketplace website. In 2015, Sameer joined Pager as the Vice president of engineering.
In this episode we cover:
Sameer’s background and how he came to his role at Pager and how he dealt with the learning curve of getting into the healthcare space, coming from an e-commerce background How Sameer delineates the difference between Artificial Intelligence and Machine Learning What this version of Pager with artificial intelligence embedded looks like and how both patients and clinicians use it How Pager uses the data gathered to help the platform get smarter over time Where Sameer sees AI in healthcare going What in healthcare innovation currently is Sameer most excited aboutLinks
Connect with Sameer
LinkedInConnect with Pager
Twitter WebsiteConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected] Listen to this episode on iTunes, SoundCloud, or Libsyn -
This week we have a great episode with Myra Hager of Baylor Scott & White Health and Dore Murphy formerly of Pager!
Myra is the Director of Digital Health at Baylor Scott & White Health (BSWH) where she manages population health innovation strategy and project execution with a goal of achieving better population health by substantially improving outcomes, driving costs down, empowering their ACO and Health plans with digital solutions, as well as create opportunities for new business models to achieve population health.
Dore was formerly the VP of Marketing at Pager, a company that is Reinventing the traditional doctor-patient experience by making quality care more convenient and accessible by sending a board-certified doctor to treat urgent care needs, at any location, summoned directly through their app. Prior to joining Pager, Dore led marketing at Sum and has a great experience working for a number of years at the New York Times
In November of 2016, BSWH and Pager announced a partnership to bring Pager’s services to BSWH’s network in the Austin area
In this episode we cover:
What the partnership between Pager and Baylor Scott & White Health looks like and the parameters of the pilot How this collaboration came together Why Health Systems are the perfect partners for Pager and the types of services that will be offered Where Dore and Myra see Telehealth playing into the future of on-demand healthcare and how Baylor Scott & White Health has approached it How Pager and Baylor Scott & White Health think about maintaining efficiency in using clinicians for their on-demand healthcare offerings Where Dore and Myra see the future of on-demand healthcare going and how it will transform the way medicine is delivered nowLinks:
Baylor Scott & White Health
Twitter WebsitePager
Twitter WebsiteMyra Hager
LinkedInDore Murphy
LinkedInConnect with Healthbox
Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at [email protected]Listen to this episode on iTunes, SoundCloud, or Libsyn
- Vis mere
